Impact of Strut Width in Periprocedural Myocardial Infarction: A Propensity-Matched Comparison Between Bioresorbable Scaffolds and the First-Generation Sirolimus-Eluting Stent.
about
Procedural resources utilization and clinical outcomes with bioresorbable everolimus-eluting scaffolds and Pt-Cr everolimus-eluting stent with resorbable abluminal polymer in clinical practice. A randomized trial.Impact of overlapping on 1-year clinical outcomes in patients undergoing everolimus-eluting bioresorbable scaffolds implantation in routine clinical practice: Insights from the European multicenter GHOST-EU registry.Quantitative assessment of the stent/scaffold strut embedment analysis by optical coherence tomography.Early experience and favorable clinical outcomes of everolimus-eluting bioresorbable scaffolds for coronary artery disease in Korea.Bioresorbable vascular scaffold use for coronary bifurcation lesions: A substudy from GHOST EU registry.
P2860
Impact of Strut Width in Periprocedural Myocardial Infarction: A Propensity-Matched Comparison Between Bioresorbable Scaffolds and the First-Generation Sirolimus-Eluting Stent.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Impact of Strut Width in Perip ...... ation Sirolimus-Eluting Stent.
@en
type
label
Impact of Strut Width in Perip ...... ation Sirolimus-Eluting Stent.
@en
prefLabel
Impact of Strut Width in Perip ...... ation Sirolimus-Eluting Stent.
@en
P2093
P50
P1476
Impact of Strut Width in Perip ...... ration Sirolimus-Eluting Stent
@en
P2093
Antonio Colombo
Filippo Figini
Hiroyoshi Kawamoto
Katsumasa Sato
Matteo Montorfano
Mauro Carlino
Tadashi Miyazaki
Toru Naganuma
Vasileios F Panoulas
P304
P356
10.1016/J.JCIN.2015.02.011
P577
2015-05-20T00:00:00Z